REPROCELL USA announced that it has received funding from MSCRF for both proposals it has submitted for the MSCRF’s January 2024 grant cycle. These two grants will help them produce Master Cell Banks for cell therapy and enhance our capacity to produce therapeutic cell products.
[REPROCELL (PR Newswire)]
